TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
-3.23%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$502M
AUM Growth
+$502M
(+41%)
Cap. Flow
+$153M
Cap. Flow
% of AUM
30.52%
Top 10 Holdings %
Top 10 Hldgs %
94.84%
Holding
17
New
6
Increased
2
Reduced
1
Closed
1
Top Buys
| 1 |
Heron Therapeutics
HRTX
|
$123M |
| 2 |
Altimmune
ALT
|
$7.72M |
| 3 |
VINC
Vincerx Pharma, Inc. Common Stock
VINC
|
$6.89M |
| 4 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$6.7M |
| 5 |
Reviva Pharmaceuticals
RVPH
|
$5.83M |
Top Sells
| 1 |
VINCW
Vincerx Pharma, Inc. Warrant
VINCW
|
$4.1M |
| 2 |
Relmada Therapeutics
RLMD
|
$3.2M |
Sector Composition
| 1 | Healthcare | 98.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Heron Therapeutics
HRTX
$207M
| $123M | 24.43% | +7,907,087 | New | +$123M |
|
2
Rocket Pharmaceuticals
RCKT
$354M
| $112M | 22.32% | 2,531,800 | – | – |
|
3
AnaptysBio
ANAB
$569M
| $68.2M | 13.57% | 2,628,678 | – | – |
|
|
ODT
4
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $54.1M | 10.78% | 15,514,566 | – | – |
|
|
LJPC
5
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $43M | 8.56% | 10,049,224 +643,734 | +7% | +$2.76M |
|
6
Aptevo Therapeutics
APVO
$5.39M
| $39.5M | 7.86% | 1,760,000 | – | – |
|
|
VINC
7
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $13.4M | 2.66% | 1,030,634 +530,634 | +106% | +$6.89M |
|
8
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $8.99M | 1.79% | 650,000 | – | – |
|
|
9
Altimmune
ALT
$338M
| $7.72M | 1.54% | +783,407 | New | +$7.72M |
|
|
CCXI
10
DELISTED
ChemoCentryx, Inc.
CCXI
| $6.7M | 1.33% | +500,000 | New | +$6.7M |
|
|
11
Reviva Pharmaceuticals
RVPH
$30.6M
| $5.83M | 1.16% | +1,200,000 | New | +$5.83M |
|
12
iTeos Therapeutics
ITOS
| $5.63M | 1.12% | +219,396 | New | +$5.63M |
|
13
Tango Therapeutics
TNGX
$747M
| $5.33M | 1.06% | 468,750 | – | – |
|
14
Equillium
EQ
$62.2M
| $3.53M | 0.7% | 600,000 | – | – |
|
|
15
Relmada Therapeutics
RLMD
$37.2M
| $3.2M | 0.64% | 100,000 -100,000 | -50% | -$3.2M |
|
16
NextCure
NXTC
$13.5M
| $2.41M | 0.48% | +300,000 | New | +$2.41M |
|
|
VINCW
17
DELISTED
Vincerx Pharma, Inc. Warrant
VINCW
| – | – | -1,014,368 | Closed | -$4.1M |
|